New Active Agents for Therapy, Diagnostics and Prophylaxis of Alzheimer and TSE-related Diseases
The invention relates to a new chemical class of compounds, which modulate the aggregation of amyloidogenetic proteins or peptides. The heterocylic or aromatic active compounds, with the general structure as shown in the figure above, are able to form a complex with amyloidogenetic proteins or peptides according to the donor-acceptor-donor pattern, leading to inhibition of the amyloid aggregation.
Next to the compounds and the use of the compounds, the invention also covers a proprietary method for the synthesis of the compounds.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Trotting robots reveal emergence of animal gait transitions
A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…
